Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Rapid HHV-6 Clearance Following Preemptive Short-Course Foscarnet in Allogeneic Stem Cell Transplant Recipients.
Journal: American journal of hematology
Published: February 15, 2026
Severe Disseminated Adenovirus Infection After Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report.
Journal: The American journal of case reports
Published: September 04, 2025
Rapid and Robust Identification of Sepsis Using SeptiCyte RAPID in a Heterogeneous Patient Population.
Journal: Journal of clinical medicine
Published: September 02, 2024
Extending duration of letermovir prophylaxis in haploidentical stem cell transplantation.
Journal: Haematologica
Published: May 04, 2024
Persistent Impairment in Immune Reconstitution and Worse Survival Outcomes in Allogeneic Stem Cell Transplantation Patients with Early Coronavirus Disease 2019 Infection.
Journal: Transplantation and cellular therapy
Published: February 19, 2024
Validation of SeptiCyte RAPID to Discriminate Sepsis from Non-Infectious Systemic Inflammation.
Journal: Journal of clinical medicine
Published: January 01, 2024
Strategies to Mitigate the Drug-Drug Interaction between Nirmatrelvir/Ritonavir and Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant Recipients on Azole Antifungals: Results of a Case Series.
Journal: Acta haematologica
Published: July 08, 2023
Once-Daily Foscarnet Is Effective for Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: January 21, 2023
A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: December 06, 2022
Tixagevimab-Cilgavimab: Utilization in the solid organ transplant population.
Journal: Clinical transplantation
Published: February 28, 2022
A Programmatic Response, Including Bamlanivimab or Casirivimab-imdevimab Administration, Reduces Hospitalization and Death in COVID-19 Positive Abdominal Transplant Recipients.
Journal: Transplantation
Published: September 14, 2021
Association of Presenting Symptoms With Abnormal Laboratory Values for Vector-Borne Illness - Experience in an Urban Gastroenterology Practice.
Journal: Journal of patient-centered research and reviews
Published: January 29, 2021
Last Updated: 09/26/2026